| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/22/1994 | CN1088113A Dispensation of Chinese herbs oral liquid adjuvant |
| 06/22/1994 | CA2111631A1 Bile acid sequestrant |
| 06/21/1994 | US5322698 Homogenizing with anhydrous alkaline earth metal salt and microcrystalline cellulose, compressing |
| 06/21/1994 | US5322694 Pharmaceutical lozenges |
| 06/21/1994 | US5322693 Lactoneotrehalose, and its preparation and uses |
| 06/21/1994 | US5322689 Copolymer of acrylic acid and fatty alcohol acrylate ester crosslinked with polyalkenyl polyether of polyhydric alcohol, volatile aromatic compound |
| 06/21/1994 | US5322685 Skin cream preparation for external use |
| 06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
| 06/21/1994 | CA2002343C Tailored beta-prime stable triglyceride hardstock |
| 06/21/1994 | CA1330378C Amine derivatives of folic acid analogs |
| 06/21/1994 | CA1330301C Stabilised human protein preparations |
| 06/21/1994 | CA1330300C Pharmaceutical preparation for therapy of immunodeficit states |
| 06/21/1994 | CA1330298C Preparations for preventing adhesions of organs and parts of organs |
| 06/21/1994 | CA1330297C Aqueous solution of fat-soluble substance |
| 06/19/1994 | CA2111773A1 Phospholipid composition |
| 06/17/1994 | CA2111560A1 Stable pharmaceutical composition of fumagillol derivatives |
| 06/17/1994 | CA2102356A1 Use of purified surface modifiers to prevent particle aggregation during sterilization |
| 06/15/1994 | EP0601979A2 Exogenous antigens bound to hepatitis B virus envelope antigen |
| 06/15/1994 | EP0601799A1 Sustained-release preparation |
| 06/15/1994 | EP0601619A2 Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| 06/15/1994 | EP0601618A2 Use of charged phospholipids for decreasing nanoparticulate aggregation |
| 06/15/1994 | EP0601417A2 Physiologically compatible and degradable polymer-based carbohydrate receptor blockers, a method for their preparation and their use |
| 06/15/1994 | EP0601318A2 Process for production of a conjugate from a specific binding partner and a carbohydrate containing protein |
| 06/15/1994 | EP0601183A1 Anti-hiv drug |
| 06/15/1994 | EP0601058A1 Transdermal formulations for administering prazosin |
| 06/15/1994 | EP0601053A1 Compositions and methods for the sublingual or buccal administration of therapeutic agents |
| 06/15/1994 | EP0600959A1 Emulsions of polar oils in water |
| 06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
| 06/15/1994 | EP0401379B1 STABILIZED COMPOSITION OF INTERLEUKIN-1$g(b) |
| 06/15/1994 | CN1025035C Prepn. of cross-linked esters of hyaluronic acid |
| 06/14/1994 | US5321095 Hydrolytic stability |
| 06/14/1994 | US5321022 Mixture of emedastine (a diazepiny/benzimidazole derivative) and aliphatic mono- and di-alkyl esters |
| 06/14/1994 | US5321014 Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells |
| 06/14/1994 | US5320956 Ovarian, esophageal and cervical carcinomas |
| 06/14/1994 | US5320942 Detecting pancreatic cells |
| 06/14/1994 | US5320906 Delivery vehicles with amphiphile-associated active ingredient |
| 06/14/1994 | US5320853 Controlled release formulation for pharmaceutical compounds |
| 06/14/1994 | US5320850 Transdermal delivery of the gestogen ST-1435 and devices therefor |
| 06/14/1994 | US5320848 Chewable drug-delivery composition |
| 06/14/1994 | US5320841 Vision disorders, ophthalmology |
| 06/14/1994 | US5320840 Continuous release pharmaceutical compositions |
| 06/14/1994 | US5320837 Controlled release preparations of active materials |
| 06/14/1994 | CA1330198C Pharmaceutical composition containing propylene glycol and urea as active main components and use thereof |
| 06/12/1994 | CA2111181A1 Process for preparing 1-substituted-6-fluoro-4-oxo-7- (1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid, a novel intermediate useful in said process, and a process for preparing said intermediate |
| 06/12/1994 | CA2111129A1 Physiologically tolerated and physiologically degradable polymer-based carbohydrate receptor blocker, a process for its preparation and its use |
| 06/12/1994 | CA2102267A1 Use of charged phospholipids to reduce nanoparticle aggregation |
| 06/10/1994 | CA2110543A1 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
| 06/09/1994 | WO1994012667A1 Inhibitors of arachidonic acid metabolites for preventing neurological damage |
| 06/09/1994 | WO1994012517A1 Sequence-specific binding polymers for duplex nucleic acids |
| 06/09/1994 | WO1994012220A2 Water soluble non-immunogenic polyamide cross-linking agents |
| 06/09/1994 | WO1994012219A2 Modified insulin-like growth factors |
| 06/09/1994 | WO1994012218A1 Process of conjugation of antiviral nucleosides with lactosaminated human albumin |
| 06/09/1994 | WO1994012217A1 Cyclodextrin and polymer based drug delivery system |
| 06/09/1994 | WO1994012216A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/09/1994 | WO1994012200A1 Dry mix formulation for bisphosphonic acids |
| 06/09/1994 | WO1994012198A1 Injectable taxol composition |
| 06/09/1994 | WO1994012196A1 Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules |
| 06/09/1994 | WO1994012193A1 Cisplatinum/oxaliplatinum combination |
| 06/09/1994 | WO1994012191A1 Pharmaceutical compositions for use in gastrointestinal washes |
| 06/09/1994 | WO1994012190A1 Health and beauty aid compositions |
| 06/09/1994 | WO1994012185A1 Combination of a calcium channel blocker and an antioxydant for treating ischemic diseases |
| 06/09/1994 | WO1994012171A1 Injectable taxane derivative based compositions |
| 06/09/1994 | WO1994012168A1 Syrup containing n-acetyl-cysteine |
| 06/09/1994 | WO1994012158A1 Controlled release growth hormone containing microspheres |
| 06/09/1994 | WO1994012157A1 Tastemasked pharmaceutical materials |
| 06/09/1994 | WO1994012156A1 Antibiotic formulation and use for drug resistant infections |
| 06/09/1994 | WO1994012155A1 Antibiotic formulation and process |
| 06/09/1994 | WO1994012153A1 A pharmaceutical formulation |
| 06/09/1994 | WO1994012031A1 Injectable composition |
| 06/09/1994 | WO1994012030A1 Injectable composition |
| 06/09/1994 | CA2308082A1 Injectable compostion |
| 06/09/1994 | CA2150554A1 Cyclodextrin and polymer based drug delivery system |
| 06/09/1994 | CA2150477A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/09/1994 | CA2149674A1 Pharmaceutical compositions for use in gastrointestinal washes |
| 06/09/1994 | CA2149048A1 Modified insulin-like growth factors |
| 06/09/1994 | CA2147472A1 Treatment of ischemic diseases using a calcium channel blocker and an antioxidant |
| 06/09/1994 | CA2135880A1 Water Soluble Non-Immunogenic Polyamide Cross-Linking Agents |
| 06/08/1994 | EP0600834A1 Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
| 06/08/1994 | EP0600730A1 Desiccant, dehydration therewith, and dehydrated product obtainable thereby |
| 06/08/1994 | EP0600532A2 Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| 06/08/1994 | EP0600529A2 Preparation and magnetic properties of very small magnetite-dextran particles |
| 06/08/1994 | EP0600395A1 Antinflammatory and analgesic diclofenac gel preparation |
| 06/08/1994 | EP0600079A1 ORAL 1$g(a)-HYDROXYPREVITAMIN D |
| 06/08/1994 | EP0600062A1 Polymer-bound paclitaxel derivatives |
| 06/08/1994 | EP0599952A1 Improved transdermal formulations |
| 06/08/1994 | EP0599943A1 Leukotriene receptor antagonist-antihistamine complex |
| 06/08/1994 | EP0467975B1 Sustained-release oral drug dosage form |
| 06/08/1994 | EP0462194B1 Fibroblast growth factor (fgf)-based stabilized compositions |
| 06/08/1994 | CN1087642A Method for delivery of cytotoxic agents and components thereof |
| 06/08/1994 | CN1087545A Medicinal composition with thrombase |
| 06/08/1994 | CN1087531A Oily preparation and method of production thereof |
| 06/08/1994 | CN1087481A Novel compositions |
| 06/07/1994 | US5319097 Pharmaceutical agents |
| 06/07/1994 | US5318960 Oil continuous solution: oil surfactant, co-solubilizer, water; viscosity |
| 06/07/1994 | US5318797 Coated particles, hollow particles, and process for manufacturing the same |
| 06/07/1994 | US5318779 Drug-impregnated ceramic |
| 06/07/1994 | US5318768 For gastrointestinal tract; film membrane, cation potentiator, particle surface modifier |
| 06/07/1994 | US5318524 Fibrin sealant delivery kit |
| 06/07/1994 | CA1330145C Protein label and drug delivery system |
| 06/07/1994 | CA1330140C Crosslinked polymers and a process for their preparation |